Meningitis Outbreak in Kent: What We Know

A recent outbreak of meningitis in Kent, England, has raised public health concerns, particularly among students at the University of Kent and Canterbury Christ Church University. As of March 19, 2026, health officials believe the outbreak is largely contained, with cases linked to a specific cluster and a known strain of the disease.

What Happened?

Two people have died as a result of the outbreak, including one student at the University of Kent. Nine cases have been confirmed, with a further 11 under investigation . Many of those infected are believed to have visited a nightclub in Canterbury between March 5th and 7th .

The Strain and Vaccine Response

The outbreak is caused by a known strain of meningitis B (MenB). A MenB vaccine, Bexsero, has been available since 2013, but is currently only routinely offered to babies born after September 2015 . This means that all current university students missed the opportunity for routine vaccination.

Approximately 5,000 students living in University of Kent halls of residence have been offered the MenB vaccine, with hundreds receiving it on Wednesday, March 17th . Antibiotics are also being administered to close contacts.

Containment Efforts and Wider Impact

Health officials are confident that the outbreak is contained, with no modern cases emerging outside the original cluster. One case was identified in London and another in France, but both individuals had recently visited Canterbury .

A case has also been confirmed at Canterbury Christ Church University, involving a student who also visited the nightclub .

Vaccine Supply and Future Considerations

Health Secretary Wes Streeting has stated that there is sufficient stock of the MenB vaccine in the country . However, pharmacy organizations report being inundated with requests from concerned parents and experiencing vaccine shortages . Some pharmacies have reported instances of abuse and intimidation from patients seeking the vaccine.

Streeting has asked the Joint Committee on Vaccination and Immunisation (JCVI) to re-examine the current eligibility criteria for the MenB vaccine, which currently limits it to babies .

Symptoms and Precautions

The UK Health Security Agency (UKHSA) has issued an alert to all NHS doctors in England, advising them to be vigilant for meningitis symptoms and to use personal protective equipment when treating suspected cases . The illness associated with this outbreak has been severe and can cause rapid deterioration.

Key Takeaways

• Two deaths have been linked to the meningitis outbreak in Kent.
• The outbreak is caused by meningitis B, and a vaccine exists, but is not routinely given to those currently affected.
• Health officials believe the outbreak is contained, with cases linked to a specific cluster.
• Vaccine supply is a concern, with pharmacies reporting shortages despite government assurances.